AstraZeneca PLC (AZN) Balance Sheet
AZN balance sheet, 2025
December 31, 2025 · U.S. dollars$114.07B assets = $65.36B liabilities + $48.72B equity
Both columns are drawn to the same scale: what AZN owns equals what it owes plus shareholders’ equity. Hover a block for its value.
AZN financial health
Descriptive bands, not a rating. Fiscal 2025.
AZN balance sheet trends, 2016–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $62.53B2016 | $114.07B2025 | +6.9%/yr | |
| Total liabilities | $45.86B2016 | $65.36B2025 | +4.0%/yr | |
| Shareholders’ equity | $14.85B2016 | $48.67B2025 | +14.1%/yr | |
| Cash & short-term investments | $5.90B2016 | $5.74B2025 | −0.3%/yr | |
| Total debt | $16.81B2016 | $29.70B2025 | +6.5%/yr | |
| Net cash (debt) | −$10.91B2016 | −$23.96B2025 | −$13.1B | |
| Working capital | −$1.99B2016 | −$1.89B2025 | +$100.0M | |
| Book value per share | $11.732016 | $31.162025 | +11.5%/yr | |
| Current ratio | 0.872016 | 0.942025 | +0.07 | |
| Debt / equity | 1.132016 | 0.612025 | −0.52 | |
| Shares outstanding | 1.27B2016 | 1.56B2025 | +2.4%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
AZN assets
AZN liabilities and equity
AZN debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
AZN balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $5.74B | $5.53B | $5.86B | $6.24B | $6.40B | $7.99B | $6.22B | $5.68B | $4.55B | $5.90B |
| Cash & equivalents | $5.71B | $5.49B | $5.84B | $6.17B | $6.33B | $7.83B | $5.37B | $4.83B | $3.32B | $5.02B |
| Short-term investments | $30.0M | $37.0M | $20.0M | $77.0M | $69.0M | $160.0M | $849.0M | $849.0M | $1.23B | $884.0M |
| Receivables | $15.18B | $11.23B | $8.41B | $9.19B | $8.13B | $5.65B | $4.90B | $3.00B | $2.80B | $2.58B |
| Inventory | $6.56B | $5.29B | $5.42B | $4.70B | $8.98B | $4.02B | $3.19B | $2.89B | $3.04B | $2.33B |
| Other current assets | $1.25B | $3.78B | $5.36B | $2.46B | $2.73B | $1.88B | $1.26B | $4.03B | $2.76B | $2.44B |
| Total current assets | $28.72B | $25.83B | $25.05B | $22.59B | $26.24B | $19.54B | $15.56B | $15.59B | $13.15B | $13.26B |
| Property, plant & equipment (net) | $14.70B | $11.65B | $10.50B | $9.45B | $10.17B | $8.92B | $8.34B | $7.42B | $7.62B | $6.85B |
| Goodwill & intangible assets | $59.09B | $58.20B | $58.14B | $59.13B | $62.38B | $32.79B | $32.50B | $33.67B | $38.01B | $39.24B |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $11.56B | $8.36B | $7.43B | $5.31B | $6.56B | $5.48B | $4.98B | $3.97B | $4.58B | $3.17B |
| Total assets | $114.07B | $104.03B | $101.12B | $96.48B | $105.36B | $66.73B | $61.38B | $60.65B | $63.35B | $62.53B |
| Liabilities | ||||||||||
| Accounts payable | $25.28B | $3.64B | $3.27B | $2.55B | $2.82B | $2.35B | $1.77B | $1.72B | $2.29B | $1.68B |
| Short-term debt | $3.57B | $2.50B | $5.40B | $5.45B | $1.80B | $2.39B | $2.01B | $1.78B | $2.27B | $2.33B |
| Deferred revenue | — | — | — | — | — | — | — | $1.37B | −$6.44B | −$5.88B |
| Total current liabilities | $30.62B | $27.87B | $30.54B | $26.29B | $22.59B | $20.31B | $18.12B | $16.29B | $16.38B | $15.26B |
| Long-term debt | $26.14B | $27.62B | $23.22B | $23.69B | $28.13B | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $1.80B | $1.45B | $1.13B | $953.0M | $987.0M | — | — | — | — | — |
| Other long-term liabilities | $8.60B | $7.68B | $8.19B | $9.44B | $15.35B | $30.78B | $28.66B | $30.32B | $30.33B | $30.60B |
| Total liabilities | $65.36B | $63.16B | $61.95B | $59.42B | $66.08B | $51.09B | $46.78B | $46.61B | $46.71B | $45.86B |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $388.0M | $388.0M | $388.0M | $387.0M | $387.0M | $328.0M | $328.0M | $317.0M | $317.0M | $316.0M |
| Retained earnings (deficit) | $10.97B | $3.16B | $4.52B | −$574.0M | $1.71B | $5.30B | $2.81B | $5.68B | $8.22B | $8.14B |
| Accumulated other comprehensive income | $2.04B | — | — | — | — | — | — | $34.0M | $1.01B | $99.0M |
| Minority interest | $52.0M | $85.0M | $23.0M | $21.0M | — | — | — | — | — | — |
| Total shareholders' equity | $48.67B | $40.79B | $39.14B | $37.04B | $39.27B | $15.62B | $13.13B | $12.47B | $14.96B | $14.85B |
| Key figures | ||||||||||
| Total debt | $29.70B | $30.11B | $28.62B | $29.14B | $30.69B | $20.38B | $18.23B | $19.11B | $17.81B | $16.81B |
| Net cash (debt) | −$23.96B | −$24.59B | −$22.76B | −$22.90B | −$24.29B | −$12.39B | −$12.01B | −$13.43B | −$13.25B | −$10.91B |
| Working capital | −$1.89B | −$2.04B | −$5.49B | −$3.70B | $3.65B | −$763.0M | −$2.55B | −$701.0M | −$3.23B | −$1.99B |
| Tangible book value | −$10.42B | −$17.42B | −$18.99B | −$22.09B | −$23.12B | −$17.17B | −$19.37B | −$21.20B | −$23.05B | −$24.39B |
| Book value per share | $31.16 | $26.09 | $25.06 | $23.74 | $27.52 | $11.90 | $10.09 | $9.84 | $11.81 | $11.73 |
| Shares outstanding | 1.56B | 1.56B | 1.56B | 1.56B | 1.43B | 1.31B | 1.30B | 1.27B | 1.27B | 1.27B |
| Current ratio | 0.94 | 0.93 | 0.82 | 0.86 | 1.16 | 0.96 | 0.86 | 0.96 | 0.80 | 0.87 |
| Quick ratio | 0.68 | 0.60 | 0.47 | 0.59 | 0.64 | 0.67 | 0.61 | 0.53 | 0.45 | 0.56 |
| Debt / equity | 0.61 | 0.74 | 0.73 | 0.79 | 0.78 | 1.30 | 1.39 | 1.53 | 1.19 | 1.13 |
| Equity / assets | 42.7% | 39.2% | 38.7% | 38.4% | 37.3% | 23.4% | 21.4% | 20.6% | 23.6% | 23.8% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $4.96B | $7.67B | $5.74B | $8.18B | $7.11B | $5.39B | $5.65B | $4.93B | $7.08B | $8.02B | $5.86B | $5.12B |
| Cash & equivalents | $4.89B | $7.56B | $5.71B | $8.14B | $7.06B | $5.23B | $5.49B | $4.80B | $6.92B | $7.84B | $5.84B | $4.87B |
| Short-term investments | $74.9M | $115.0M | $30.0M | $39.0M | $50.0M | $165.0M | $166.0M | $133.0M | $160.0M | $180.0M | $20.0M | $244.0M |
| Receivables | $15.97B | $14.11B | $15.18B | $14.34B | $14.17B | $13.25B | $12.97B | $11.88B | $11.05B | $11.07B | $10.51B | $11.30B |
| Inventory | $6.92B | $6.57B | $6.56B | $6.59B | $6.47B | $5.88B | $5.29B | $5.66B | $5.67B | $5.34B | $5.42B | $5.29B |
| Other current assets | $75.9M | $1.26B | $1.25B | $827.0M | $1.20B | $1.61B | $1.91B | $1.68B | $1.60B | $1.16B | $3.26B | $794.0M |
| Total current assets | $27.93B | $29.61B | $28.72B | $29.94B | $28.94B | $26.14B | $25.83B | $24.16B | $25.39B | $25.59B | $25.05B | $22.50B |
| Property, plant & equipment (net) | $16.28B | $14.94B | $14.70B | $13.78B | $13.23B | $12.30B | $11.65B | $11.51B | $10.83B | $10.62B | $10.50B | $9.70B |
| Goodwill & intangible assets | $58.84B | $58.10B | $59.09B | $59.41B | $59.15B | $58.68B | $58.20B | $60.53B | $60.49B | $58.81B | $58.14B | $57.63B |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $12.65B | $11.36B | $11.56B | $11.32B | $11.11B | $9.13B | $8.36B | $8.72B | $7.63B | $7.27B | $7.43B | $6.26B |
| Total assets | $115.70B | $114.02B | $114.07B | $114.46B | $112.42B | $106.25B | $104.03B | $104.92B | $104.34B | $102.29B | $101.12B | $96.09B |
| Liabilities | ||||||||||||
| Accounts payable | $22.87B | $22.50B | $25.28B | $25.03B | $23.99B | $22.54B | $22.46B | $21.68B | $20.46B | $19.70B | $3.27B | $20.54B |
| Short-term debt | $6.23B | $7.96B | $3.57B | $6.58B | $6.85B | $3.78B | $2.50B | $1.57B | $5.36B | $6.33B | $5.40B | $5.61B |
| Total current liabilities | $31.52B | $32.57B | $30.62B | $34.05B | $33.54B | $29.13B | $27.87B | $25.93B | $28.57B | $28.90B | $30.54B | $28.59B |
| Long-term debt | $23.68B | $24.45B | $26.14B | $26.08B | $25.99B | $26.69B | $26.51B | $28.89B | $0 | $0 | $0 | $0 |
| Lease obligations | $2.75B | $1.89B | $1.80B | $1.76B | $1.63B | $1.55B | $1.45B | $1.42B | — | — | — | — |
| Other long-term liabilities | $10.19B | $9.61B | $8.60B | $8.35B | $8.09B | $9.30B | $8.79B | $9.30B | $36.18B | $35.89B | $31.41B | $30.28B |
| Total liabilities | $65.39B | $66.63B | $65.36B | $68.48B | $67.61B | $65.12B | $63.16B | $64.12B | $64.74B | $64.79B | $61.95B | $58.87B |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $387.5M | $388.0M | $388.0M | $388.0M | $388.0M | $388.0M | $388.0M | $388.0M | $388.0M | $388.0M | $388.0M | $387.0M |
| Retained earnings (deficit) | $12.58B | $9.67B | $10.97B | $8.21B | $7.02B | $3.36B | $3.16B | $3.14B | $1.85B | −$212.0M | $1.50B | −$434.0M |
| Accumulated other comprehensive income | $2.03B | — | $2.04B | $2.04B | $2.07B | $2.05B | — | $1.99B | — | — | — | — |
| Minority interest | $75.0M | $51.0M | $52.0M | $83.0M | $91.0M | — | — | — | — | — | — | — |
| Total shareholders' equity | $50.24B | $47.33B | $48.67B | $45.89B | $44.72B | $41.04B | $40.79B | $40.72B | $39.51B | $37.45B | $39.14B | $37.20B |
| Key figures | ||||||||||||
| Total debt | $32.20B | $33.92B | $29.70B | $32.66B | $32.84B | $31.72B | $30.11B | $31.56B | $33.53B | $34.55B | $28.62B | $28.58B |
| Net cash (debt) | −$27.24B | −$26.24B | −$23.96B | −$24.48B | −$25.73B | −$26.32B | −$24.46B | −$26.63B | −$26.46B | −$26.53B | −$22.76B | −$23.46B |
| Working capital | −$3.58B | −$2.96B | −$1.89B | −$4.11B | −$4.60B | −$2.99B | −$2.04B | −$1.77B | −$3.17B | −$3.31B | −$5.49B | −$6.09B |
| Tangible book value | −$8.60B | −$10.77B | −$10.42B | −$13.52B | −$14.43B | −$17.64B | −$17.42B | −$19.81B | −$20.97B | −$21.37B | −$18.99B | −$20.43B |
| Book value per share | $32.20 | $30.32 | $31.16 | $29.40 | $28.68 | $26.29 | $26.11 | $26.10 | $25.33 | $24.00 | $25.08 | $23.84 |
| Shares outstanding | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B |
| Current ratio | 0.89 | 0.91 | 0.94 | 0.88 | 0.86 | 0.90 | 0.93 | 0.93 | 0.89 | 0.89 | 0.82 | 0.79 |
| Quick ratio | 0.66 | 0.67 | 0.68 | 0.66 | 0.63 | 0.64 | 0.67 | 0.65 | 0.63 | 0.66 | 0.54 | 0.57 |
| Debt / equity | 0.64 | 0.72 | 0.61 | 0.71 | 0.73 | 0.77 | 0.74 | 0.78 | 0.85 | 0.92 | 0.73 | 0.77 |
| Equity / assets | 43.4% | 41.5% | 42.7% | 40.1% | 39.8% | 38.6% | 39.2% | 38.8% | 37.9% | 36.6% | 38.7% | 38.7% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed February 24, 2026); data from EODHD.
AZN financial position
At the end of fiscal 2025 (December 31, 2025), AstraZeneca had total assets of $114.1 billion (up 9.6% from a year earlier), total liabilities of $65.4 billion and shareholders' equity of $48.7 billion. It held $5.7 billion in cash and short-term investments against $29.7 billion of debt, net debt of $24.0 billion. Its current ratio was 0.94. In the latest quarter (ended June 30, 2026) total assets were $115.7 billion and equity $50.2 billion.
Related: AZN income statement, AZN cash flow statement, AZN key metrics. See the AZN stock overview for the latest quote and news.
AZN balance sheet FAQ
What are AstraZeneca's total assets?
AstraZeneca reported total assets of $114.1 billion at the end of fiscal 2025 (December 31, 2025), compared with $104.0 billion a year earlier.
How much debt does AstraZeneca have?
AstraZeneca had $29.7 billion of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.61.
How much cash does AstraZeneca have?
AstraZeneca held $5.7 billion in cash and short-term investments at the end of fiscal 2025; with $29.7 billion of debt that is net debt of $24.0 billion.
What is AstraZeneca's book value?
AstraZeneca's shareholders' equity (book value) was $48.7 billion at the end of fiscal 2025, or $31.16 per share.
What is AstraZeneca's current ratio?
AstraZeneca had current assets of $28.7 billion and current liabilities of $30.6 billion, a current ratio of 0.94 (current liabilities exceed current assets).
How much goodwill does AstraZeneca have?
AstraZeneca carried $59.1 billion of goodwill and intangible assets, 51.8% of total assets, at the end of fiscal 2025.